Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections

W. Crombleholme, D. Landers, M. Ohm-Smith, M. O. Robbie, W. K. Hadley, V. DeKay, D. Dahrouge, Richard L Sweet

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The clinical efficacy and safety of sulbactam/ampicillin versus metronidazole/gentamicin were compared in 39 patients with severe pelvic infections. 30 patients had severe acute pelvic inflammatory disease with peritonitis, 3 tubo-ovarian abscesses, 4 endomyometritis, and 2 posthysterectomy pelvic cellulitis. Aerobic and anaerobic cultures from the sites of infection yielded 259 micro-organisms from 38 patients; an average of 6.8 h bacteria per infection (3.9 anaerobes and 2.9 aerobes). The most frequent isolates were Bacteroides spp. (21). B. bivius (13), B. disiens (8), Fusobacterium spp. (9), Peptostreptococcus anaerobius (15), P. asaccharolyticus (8), anaerobic Gram-positive cocci (17), Gardnerella vaginalis (24), Neisseria gonorrhoeae (14), α-haemolytic streptococci (6) and Escherichia coli (3). Clinical cure was noted in 19 of 20 patients treated with sulbactam/ampicillin and 16 of 19 treated with metronidazole/gentamicin. The sulbactam/ampicillin failure was a patient with pelvic inflammatory disease with a positive Chlamydia trachomatis culture who required antichlamydial therapy. The metronidazole/gentamicin failures included a patient with a tube-ovarian abscess requiring surgical drainage and 2 patients with pelvic inflammatory disease requiring antichlamydial treatment. No adverse haematological, renal, or hepatic effects were noted with either regimen.

Original languageEnglish (US)
Pages (from-to)11-13
Number of pages3
JournalDrugs
Volume31
Issue numberSUPPL. 2
StatePublished - 1986

Fingerprint

Pelvic Infection
Metronidazole
Gentamicins
Pelvic Inflammatory Disease
Escherichia coli
Drainage
Bacteria
Abscess
Therapeutics
Parametritis
Gardnerella vaginalis
Fusobacterium
Peptostreptococcus
Endometritis
Gram-Positive Cocci
Bacteroides
Neisseria gonorrhoeae
Chlamydia trachomatis
Infection
sultamicillin

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Crombleholme, W., Landers, D., Ohm-Smith, M., Robbie, M. O., Hadley, W. K., DeKay, V., ... Sweet, R. L. (1986). Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. Drugs, 31(SUPPL. 2), 11-13.

Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. / Crombleholme, W.; Landers, D.; Ohm-Smith, M.; Robbie, M. O.; Hadley, W. K.; DeKay, V.; Dahrouge, D.; Sweet, Richard L.

In: Drugs, Vol. 31, No. SUPPL. 2, 1986, p. 11-13.

Research output: Contribution to journalArticle

Crombleholme, W, Landers, D, Ohm-Smith, M, Robbie, MO, Hadley, WK, DeKay, V, Dahrouge, D & Sweet, RL 1986, 'Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections', Drugs, vol. 31, no. SUPPL. 2, pp. 11-13.
Crombleholme W, Landers D, Ohm-Smith M, Robbie MO, Hadley WK, DeKay V et al. Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. Drugs. 1986;31(SUPPL. 2):11-13.
Crombleholme, W. ; Landers, D. ; Ohm-Smith, M. ; Robbie, M. O. ; Hadley, W. K. ; DeKay, V. ; Dahrouge, D. ; Sweet, Richard L. / Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. In: Drugs. 1986 ; Vol. 31, No. SUPPL. 2. pp. 11-13.
@article{662e973b144f48729f58937fdcd3e578,
title = "Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections",
abstract = "The clinical efficacy and safety of sulbactam/ampicillin versus metronidazole/gentamicin were compared in 39 patients with severe pelvic infections. 30 patients had severe acute pelvic inflammatory disease with peritonitis, 3 tubo-ovarian abscesses, 4 endomyometritis, and 2 posthysterectomy pelvic cellulitis. Aerobic and anaerobic cultures from the sites of infection yielded 259 micro-organisms from 38 patients; an average of 6.8 h bacteria per infection (3.9 anaerobes and 2.9 aerobes). The most frequent isolates were Bacteroides spp. (21). B. bivius (13), B. disiens (8), Fusobacterium spp. (9), Peptostreptococcus anaerobius (15), P. asaccharolyticus (8), anaerobic Gram-positive cocci (17), Gardnerella vaginalis (24), Neisseria gonorrhoeae (14), α-haemolytic streptococci (6) and Escherichia coli (3). Clinical cure was noted in 19 of 20 patients treated with sulbactam/ampicillin and 16 of 19 treated with metronidazole/gentamicin. The sulbactam/ampicillin failure was a patient with pelvic inflammatory disease with a positive Chlamydia trachomatis culture who required antichlamydial therapy. The metronidazole/gentamicin failures included a patient with a tube-ovarian abscess requiring surgical drainage and 2 patients with pelvic inflammatory disease requiring antichlamydial treatment. No adverse haematological, renal, or hepatic effects were noted with either regimen.",
author = "W. Crombleholme and D. Landers and M. Ohm-Smith and Robbie, {M. O.} and Hadley, {W. K.} and V. DeKay and D. Dahrouge and Sweet, {Richard L}",
year = "1986",
language = "English (US)",
volume = "31",
pages = "11--13",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections

AU - Crombleholme, W.

AU - Landers, D.

AU - Ohm-Smith, M.

AU - Robbie, M. O.

AU - Hadley, W. K.

AU - DeKay, V.

AU - Dahrouge, D.

AU - Sweet, Richard L

PY - 1986

Y1 - 1986

N2 - The clinical efficacy and safety of sulbactam/ampicillin versus metronidazole/gentamicin were compared in 39 patients with severe pelvic infections. 30 patients had severe acute pelvic inflammatory disease with peritonitis, 3 tubo-ovarian abscesses, 4 endomyometritis, and 2 posthysterectomy pelvic cellulitis. Aerobic and anaerobic cultures from the sites of infection yielded 259 micro-organisms from 38 patients; an average of 6.8 h bacteria per infection (3.9 anaerobes and 2.9 aerobes). The most frequent isolates were Bacteroides spp. (21). B. bivius (13), B. disiens (8), Fusobacterium spp. (9), Peptostreptococcus anaerobius (15), P. asaccharolyticus (8), anaerobic Gram-positive cocci (17), Gardnerella vaginalis (24), Neisseria gonorrhoeae (14), α-haemolytic streptococci (6) and Escherichia coli (3). Clinical cure was noted in 19 of 20 patients treated with sulbactam/ampicillin and 16 of 19 treated with metronidazole/gentamicin. The sulbactam/ampicillin failure was a patient with pelvic inflammatory disease with a positive Chlamydia trachomatis culture who required antichlamydial therapy. The metronidazole/gentamicin failures included a patient with a tube-ovarian abscess requiring surgical drainage and 2 patients with pelvic inflammatory disease requiring antichlamydial treatment. No adverse haematological, renal, or hepatic effects were noted with either regimen.

AB - The clinical efficacy and safety of sulbactam/ampicillin versus metronidazole/gentamicin were compared in 39 patients with severe pelvic infections. 30 patients had severe acute pelvic inflammatory disease with peritonitis, 3 tubo-ovarian abscesses, 4 endomyometritis, and 2 posthysterectomy pelvic cellulitis. Aerobic and anaerobic cultures from the sites of infection yielded 259 micro-organisms from 38 patients; an average of 6.8 h bacteria per infection (3.9 anaerobes and 2.9 aerobes). The most frequent isolates were Bacteroides spp. (21). B. bivius (13), B. disiens (8), Fusobacterium spp. (9), Peptostreptococcus anaerobius (15), P. asaccharolyticus (8), anaerobic Gram-positive cocci (17), Gardnerella vaginalis (24), Neisseria gonorrhoeae (14), α-haemolytic streptococci (6) and Escherichia coli (3). Clinical cure was noted in 19 of 20 patients treated with sulbactam/ampicillin and 16 of 19 treated with metronidazole/gentamicin. The sulbactam/ampicillin failure was a patient with pelvic inflammatory disease with a positive Chlamydia trachomatis culture who required antichlamydial therapy. The metronidazole/gentamicin failures included a patient with a tube-ovarian abscess requiring surgical drainage and 2 patients with pelvic inflammatory disease requiring antichlamydial treatment. No adverse haematological, renal, or hepatic effects were noted with either regimen.

UR - http://www.scopus.com/inward/record.url?scp=0022534401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022534401&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 11

EP - 13

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - SUPPL. 2

ER -